|
Ferrous Sulfate |
|
Trade Name: |
Fer-In-Sol |
|
Therapeutic Class: |
20:04.04 |
|
Contraindications: |
Hemochromatosis, hemolytic anemia; know hypersensitivity to iron salts |
|
Usual Dosage |
|
Infants, preterm (dose expressed in terms of elemental iron) |
|
|
<1000 grams: 4 mg/kg/24 hours
1000-1500 grams: 3 mg/kg/24 hours
1500-2500 grams: 2 mg/kg/24 hours |
|
Children (dose expressed in terms of elemental iron) |
|
Oral: |
4-6 mg Fe/kg/24 hours in 3 divided doses |
|
Mild to moderate iron deficiency anemia |
|
Oral: |
3 mg Fe/kg/24 hours in 1-2 divided doses |
|
Prophylaxis for iron deficiency anemia |
|
Oral: |
1-2 mg Fe/kg/24 hours up to a maximum of 15 mg/24 hours |
|
Adults (dose expressed in terms of ferrous sulfate) |
|
Iron deficiency anemia |
|
Oral: |
300 mg twice daily up to 300mg 4 times/day |
|
Prophylaxis for iron deficiency anemia |
|
Oral: |
300 mg/24 hours |
|
Dosage Form |
|
Drops: |
75 mg/0.6 ml (15 mg elemental iron/0.6 ml) |
|
Tablet: |
325 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Iron deficiency anemia in children and adults. Note: When prescribing in children be sure to advise caregivers to keep this medication out of reach of children. Iron overdose is a common cause of death. |
|
Flu Vaccine |
|
Trade Name: |
Fluzone |
|
Therapeutic Class: |
80:12 Vaccines |
|
Contraindications: |
Delay immunization in a patient with an active neurological disorder; do not administer to patients with acute respiratory or other active infections or illnesses; hypersensitivity
to thimerosal, hypersensitivity to eggs or egg products, chicken, chicken feathers or chicken dander; not approved for infants under six months of age. |
|
Usual Dosage |
|
Children 3-8 years |
|
IM: |
0.5 ml, one or two doses* |
|
Adults: |
|
IM: |
0.5 ml, one dose |
|
* Two doses are recommended for children < 9 years of age who are receiving influenza virus vaccine for the first time; with the two dose regimen allow >4 weeks between doses |
|
Dosage Form |
|
Injection: |
0.5 ml |
|
Authorized Prescribers: |
MD only |
|
Comments: |
Flu vaccine is approved for patients with the following conditions: asthma or any chronic pulmonary disease, hemodynamically significant cardiac disease, immunosuppressive disorders or therapy, HIV, sickle cell disease, long term aspirin therapy, chronic renal dysfunction, diabetes or other chronic metabolic diseases, and all patients over 65 years of age. |
|
Fluconazole |
|
Trade Name: |
Diflucan |
|
Therapeutic Class: |
08:12.04 Antifungal Antibiotics |
|
Contraindications: |
Known hypersensitivity to fluconazole or other azoles |
|
Usual Dosage |
|
Adults: |
|
Oral: |
200 mg loading dose; followed by a maintenance dose of 100 mg once a day; can use 150 mg po once for vaginal candidiasis. |
|
Dosage Form |
|
Tablet: |
50 mg, 100 mg, 150 mg, 200 mg |
|
Authorized Prescribers: |
MD/DDS/NP/PA |
|
Comments: |
NP/PA: For use in oral candidiasis only |
|
Fluocinonide 0.05% |
|
Trade Name: |
Lidex |
|
Therapeutic Class: |
84:06 Anti-inflammatory Agents (Skin and Mucous Membrane) |
|
Contraindications: |
Hypersensitivity to any component, primary bacterial infections, Candida and dermatophytes, herpes simplex, and zoster. |
|
Usual Dosage |
|
Adolescents and Adults |
|
Topical: |
Apply 1-2 times daily to only the affected area. |
|
Dosage Form |
|
Topical: |
0.05% Fluocinonide ointment |
|
Authorized Prescribers: |
MD/DDS/NP/PA |
|
Comments: |
NP/PA: contact dermatitis and moderate to severe atopic dermatitis. Medication should never be used for longer than a two-week period of time without a discontinuation prior to re-starting. This and other fluorinated compounds should never be used on the face unless instructed by a dermatologist. |
|
Flunisolide |
|
Trade Name: |
Nasalide |
|
Therapeutic Class: |
52:08 Anti-Inflammatory Agents |
|
Contraindications: |
Hypersensitivity to flunisolide or any component. |
|
Usual Dosage |
|
Adults: |
|
Nasal: |
Two sprays each nostril twice daily |
|
Dosage Form |
|
Nasal: |
0.025% 25 mcg/actuation |
|
Authorized Prescribers: |
MD/DDS/NP/PA |
|
Comments: |
None |
|
Fluoxetine |
|
Trade Name: |
Prozac |
|
Therapeutic Class: |
28:16.04 Antidepressants |
|
Contraindications: |
Known hypersensitivity to fluoxetine; patients receiving MAO inhibitors currently or in the past 2 weeks |
|
Usual Dosage |
|
Adults: |
|
Oral: |
20 mg/day in the morning (up to a maximum of 80 mg/day); doses above 20 mg should be divided into morning and none doses; full effect may require 4 weeks or longer of treatment |
|
Dosage Form |
|
Capsule: |
10 mg, 20 mg |
|
Liquid: |
20 mg/5 ml |
|
Authorized Prescribers: |
MD/Psychiatry |
|
Comments: |
Further information about the use of fluoxetine can be found in the DIHS clinical practice guidelines for the treatment of depression. |
|
Fluphenazine Decanoate |
|
Trade Name: |
Prolixin Decanoate |
|
Therapeutic Class: |
28:16.08 Antipsychotic Agents |
|
Contraindications: |
Known hypersensitivity to fluphenazine or any component; narrow angle glaucoma, bone marrow suppression, CNS depression, liver or cardiac disease. |
|
Usual Dosage |
|
Adults: |
|
Injection: |
12.5 - 25 mg |
|
Dosage Form |
|
Injectable: |
25 mg/ml |
|
Authorized Prescribers: |
MD/Psychiatry |
|
Comments: |
None |
|
Fluvastatin |
|
Trade Name: |
Lescol |
|
Therapeutic Class: |
24:06 Antilipemic Agents |
|
Contraindications: |
Known hypersensitivity to fluvastatin or any component; should not be used in patients with active liver disease. |
|
Usual Dosage |
|
Adults: |
|
Oral: |
Initial: 10-20 mg with evening meal; dosage can be increased to 20 mg 2 times/day and then 40 mg 2 times/day |
|
Dosage Form |
|
Tablet: |
20 mg, 40 mg |
|
Authorized Prescribers: |
MD only |
|
Comments: |
The combination of a statin with cyclosporine, fibric acid derivatives, erythromycin, or niacin increase the risk of toxicity, and so these combinations must be used with caution. |
|
Folic Acid |
|
Trade Name: |
Folvite |
|
Therapeutic Class: |
88:08 Vitamin B Complex |
|
Contraindications: |
Pernicious, aplastic, or normocytic anemias |
|
Usual Dosage |
|
Children <11 yrs |
|
Oral: |
Initial: 0.5-1.0 mg/24 hours; maintenance dose: 0.1-0.3 mg/day |
|
Children >11 yrs-Adults |
|
Oral: |
Initial: 1.0 mg/day; maintenance dose: 0.5 mg/day |
|
Dosage Form |
|
Tablet: |
1 mg |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Furazolidone |
|
Trade Name: |
Furoxone |
|
Therapeutic Class: |
08:40 Miscellaneous Anti-Infectives |
|
Contraindications: |
Known hypersensitivity to furazolidone; concurrent use of alcohol; patients <1 month of age because of the possibility of producing hemolytic anemia; MAO inhibitors,
tyramine-containing foods. |
|
Usual Dosage |
|
Children >1 month |
|
Oral: |
5-8.8 mg/kg/24 hours in 4 divided doses, not to exceed 400 mg/24 hours |
|
Adults: |
|
Oral: |
100 mg 4 times/day |
|
Dosage Form |
|
Liquid: |
50 mg/15 ml |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Furosemide |
|
Trade Name: |
Lasix |
|
Therapeutic Class: |
40:28 Diuretics |
|
Contraindications: |
Hypersensitivity to furosemide or any component |
|
Usual Dosage |
|
Adults: |
|
Oral: |
Initial: 20-80 mg/dose, increase in increments of 20-40 mg/dose at intervals of 6-8 hours; usual maintenance dose interval is every day or twice daily |
|
IV, IM: |
Initial: 20-40 mg/dose, repeated in 1-2 hours as needed; doses may be increased by 20 mg/dose with each dose; usual dosage interval: 6-12 hours |
|
Dosage Form |
|
Injectable: |
10 mg/ml |
|
Solution: |
10 mg/ml; 40 mg/5 ml |
|
Tablet: |
20 mg, 40 mg, 80 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Congestive heart failure (may use IV route if patient is acutely ill) |
|
|
|
|
|
|
|
|
|